Equities

Metropolis Healthcare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
METROPOLIS:NSI

Metropolis Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)1,885.30
  • Today's Change-89.70 / -4.54%
  • Shares traded210.11k
  • 1 Year change-8.31%
  • Beta0.7499
Data delayed at least 15 minutes, as of Jul 11 2025 11:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. The Company has a single operating segment, namely Pathology service. It is mainly engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company serves both the business-to-business (B2B) and business-to-customer (B2C) markets. It offers a comprehensive range of over 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The Company operates approximately 200 clinical laboratories and 4,300 service centers across 22 states in India.

  • Revenue in INR (TTM)13.31bn
  • Net income in INR1.45bn
  • Incorporated2000
  • Employees4.31k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
METROPOLIS:NSI since
announced
Transaction
value
Core Diagnostics Pvt LtdDeal completed09 Dec 202409 Dec 2024Deal completed-11.98%29.15m
Data delayed at least 15 minutes, as of Jul 11 2025 11:26 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shalby Ltd10.87bn62.22m19.54bn2.85k466.471.9728.881.800.39060.3906110.6292.500.65652.296.80--0.11593.890.15224.6541.5856.510.17666.310.7441.730.323518.6116.3817.43-92.60-25.7629.30--
Krsnaa Diagnostics Ltd7.17bn776.10m26.36bn3.70k34.522.9715.893.6823.5423.54217.54273.390.58465.193.16--6.339.968.3212.6376.4079.7910.8216.811.264.130.1874--15.7422.6536.54--10.53--
Artemis Medicare Services Ltd9.37bn826.26m34.96bn2.08k47.544.1327.463.735.295.2960.1760.880.80460.00059.384,510,914.007.064.988.586.26----8.775.882.453.340.2565.886.6410.6468.1433.0829.07--
Medi Assist Healthcare Services Ltd7.23bn909.62m40.04bn3.82k44.20--27.175.5412.8412.83102.07------------9.53--16.31----12.6613.14--9.55----13.9617.8231.7318.3517.38--
Indraprastha Medical Corporation Ltd13.56bn1.61bn44.70bn2.98k27.767.4921.773.3017.5617.56147.9565.091.7280.6720.27--20.4415.3126.1620.0156.8257.1811.878.312.3731.890.05230.778.9710.3029.8729.84-2.35--
Thyrocare Technologies Ltd6.87bn915.00m57.52bn1.82k62.5210.5239.368.3717.3617.36130.42103.171.034.0611.803,772,503.0013.6017.0716.1819.9272.2069.6013.2217.912.3939.730.043299.5120.199.6729.320.691635.3033.24
Yatharth Hospital & Trauma Cre Srvcs Ltd8.80bn1.31bn58.78bn2.19k40.443.6631.316.6815.0915.09101.88166.620.640212.283.33--9.4911.5310.1713.2379.7278.4414.8313.879.8764.220.007--31.3143.2414.04--48.32--
Healthcare Global Enterprises Ltd22.18bn444.10m77.95bn6.15k177.498.4529.963.513.153.15157.0466.170.709722.206.38--1.56-0.61092.24-0.827852.1153.142.20-0.90480.75571.110.6498--16.2615.22-7.78--14.14--
Metropolis Healthcare Ltd13.31bn1.45bn97.67bn4.31k66.907.3438.427.3428.1828.18258.84256.940.77796.459.71--8.5011.8210.1214.4579.0576.4710.9313.791.0110.460.1327--10.239.2213.422.6313.64--
Jupiter Life Line Hospitals Ltd12.62bn1.94bn98.15bn2.83k50.727.2439.197.7829.5129.51192.40206.850.79199.8325.464,460,909.0012.159.4313.2210.6281.7681.6015.3411.074.3422.700.22470.0017.9622.209.5645.5462.17--
Vijaya Diagnostic Centre Ltd6.81bn1.43bn104.79bn2.05k73.3113.1648.8815.3813.9213.9266.2977.530.60416.7643.96--12.7513.7214.2715.1287.5685.9221.1021.541.867.580.28579.4624.3915.0020.4118.0014.98--
Data as of Jul 11 2025. Currency figures normalised to Metropolis Healthcare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

33.32%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 May 20255.01m9.77%
UTI Asset Management Co. Ltd. (Investment Management)as of 02 Jan 20252.66m5.18%
JPMorgan Asset Management (UK) Ltd.as of 03 Jul 20251.81m3.53%
Kotak Mahindra Asset Management Co. Ltd.as of 31 May 20251.53m2.98%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 May 20251.30m2.53%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 20251.18m2.30%
The Vanguard Group, Inc.as of 02 Jul 2025947.70k1.85%
First Sentier Investors (Singapore)as of 31 Mar 2025933.63k1.82%
Tata Asset Management Pvt Ltd.as of 30 Jun 2025878.93k1.71%
Sundaram Asset Management Co. Ltd.as of 31 May 2025845.34k1.65%
More ▼
Data from 31 Mar 2025 - 04 Jul 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.